Edmonds Duncan Registered Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$849K Buy
958
+109
+13% +$98K 0.19% 60
2024
Q2
$769K Hold
849
0.19% 59
2024
Q1
$660K Buy
849
+55
+7% +$39.1K 0.17% 63
2023
Q4
$463K Buy
794
+45
+6% +$26.3K 0.12% 72
2023
Q3
$402K Buy
749
+200
+36% +$103K 0.11% 84
2023
Q2
$257K Buy
+549
New +$230K 0.08% 105

Other funds holding LLY

Edmonds Duncan Registered Investment Advisors's LLY Position: Q3 2024 in Review

Edmonds Duncan Registered Investment Advisors increased its Eli Lilly (LLY) stake by 13% in Q3 2024, buying an estimated $98K and bringing the position to 958 shares worth $849K. The position accounts for 0.19% of the portfolio, ranked #60.

Edmonds Duncan Registered Investment Advisors first reported a position in LLY in Q2 2023 and has held it in 6 quarters since. 3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Edmonds Duncan Registered Investment Advisors held 958 shares of Eli Lilly worth $849K as of Q3 2024.
  • Edmonds Duncan Registered Investment Advisors bought 109 Eli Lilly shares in Q3 2024, an estimated $98K.
  • Eli Lilly made up 0.19% of Edmonds Duncan Registered Investment Advisors's portfolio in Q3 2024, its #60 holding.
  • Edmonds Duncan Registered Investment Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 6 quarters since.
  • 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.